BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3079085)

  • 21. OKT3 immunoprophylaxis in human liver transplantation.
    Mühlbacher F; Steininger R; Längle F; Sautner T; Gnant M; Götzinger P; Piza F; Popow T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2253-4. PubMed ID: 2652731
    [No Abstract]   [Full Text] [Related]  

  • 22. FK 506 treatment of intractable rejection after liver transplantation.
    Jost U; Winkler M; Ringe B; Rodeck B; Pichlmayr R
    Transplant Proc; 1993 Aug; 25(4):2686-7. PubMed ID: 7689276
    [No Abstract]   [Full Text] [Related]  

  • 23. Quadruple-drug therapy with antithymocyte globulin in the early postoperative period after liver transplantation.
    Schattenfroh N; Lange D; Bechstein WO; Blumhardt G; Lohmann R; Neuhaus P
    Transplant Proc; 1993 Apr; 25(2):1968-9. PubMed ID: 8470245
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of cyclosporine dosing on creatinine levels in hepatic transplant recipients.
    Gross CR; Savik SK; Ascher NL; Gordon RD; Klintmalm GB; Payne W; Shaw BW; Strasburg K; Parker A; Wiesner RH
    Transplant Proc; 1994 Oct; 26(5):2686-90. PubMed ID: 7940841
    [No Abstract]   [Full Text] [Related]  

  • 25. Improvement of renal function after conversion from cyclosporine only to prednisolone-azathioprine followed by late-onset graft failure in renal transplant patients.
    Tegzess AM; van Son WJ; Beelen JM; Sluiter WJ; Meijer S; Slooff MJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2000-4. PubMed ID: 3547904
    [No Abstract]   [Full Text] [Related]  

  • 26. The long-term results of thoracic duct drainage in living related kidney transplantation.
    Ohshima S; Ono Y; Kinukawa T; Matsuura O; Takeuchi N; Hattori R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1972-3. PubMed ID: 2652644
    [No Abstract]   [Full Text] [Related]  

  • 27. Cyclosporine A monitoring in liver transplant.
    Tisone G; Vennarecci G; Pisani F; Pieragostini E; Alciati E; Casciani CU
    Transplant Proc; 1994 Oct; 26(5):2691-2. PubMed ID: 7940842
    [No Abstract]   [Full Text] [Related]  

  • 28. Successful pregnancy after orthotopic liver transplantation.
    Haagsma EB; Visser GH; Klompmaker IJ; Verwer R; Slooff MJ
    Obstet Gynecol; 1989 Sep; 74(3 Pt 2):442-3. PubMed ID: 2668820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corticosteroid withdrawal with substitution of azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients.
    Kupin W; Venkat KK; Florence-Green D; Norris C; Oh HK; Dienst S; Levin NW
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2024-6. PubMed ID: 3274465
    [No Abstract]   [Full Text] [Related]  

  • 30. Elective conversion from cyclosporine to azathioprine: long-term follow-up.
    Veitch PS; Taylor JD; Feehally J; Walls J; Bell PR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2017. PubMed ID: 3079067
    [No Abstract]   [Full Text] [Related]  

  • 31. Impairment of liver synthetic function and decreased liver flow during cyclosporine A therapy.
    Leunissen KM; Teule J; Degenaar CP; Kho TL; Frenken LA; van Hooff JP
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1822-4. PubMed ID: 3274429
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of triple therapy and percutaneous needle biopsy to minimize graft failure following liver transplantation.
    St Cyr JA; Elick B; Freese D; Sharp H; Payne W; Bloomer J; Stock P; Snover D; Najarian JS; Ascher NL
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2451-3. PubMed ID: 3274535
    [No Abstract]   [Full Text] [Related]  

  • 33. Amelioration of 3.5-hour warm ischemia time for pig livers by cyclosporine pretherapy, compared with azathioprine.
    Kim YI; Kawano K; Goto S; Ono M; Iwao Y; Kobayashi M
    Transplant Proc; 1991 Feb; 23(1 Pt 1):655-6. PubMed ID: 1990637
    [No Abstract]   [Full Text] [Related]  

  • 34. Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection.
    Wiesner RH; Porayko MK; Wahlstrom HE; Gores GJ; Kamath PS; Hay JE; Krom RA
    Transplant Proc; 1993 Apr; 25(2):1791-3. PubMed ID: 7682352
    [No Abstract]   [Full Text] [Related]  

  • 35. Improved early course after cadaveric renal transplantation by reducing the cyclosporine dose and adding azathioprine.
    Lundgren G; Albrechtsen D; Brynger H; Flatmark A; Frödin I; Gäbel H; Persson H; Groth CG
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2074-9. PubMed ID: 3547910
    [No Abstract]   [Full Text] [Related]  

  • 36. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine.
    Chapman JR; Morris PJ
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664
    [No Abstract]   [Full Text] [Related]  

  • 37. The mechanism of hyperuricaemia in cyclosporine-treated renal transplant recipients.
    Cohen SL; Boner G; Rosenfeld JB; Shmueli D; Sperling O; Yusim A; Todd-Pokropek A; Shapira Z
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1829-30. PubMed ID: 3079042
    [No Abstract]   [Full Text] [Related]  

  • 38. Intensive care after orthotopic liver transplantation.
    Sun CK; Chen CL; Kuo YC; Chen YS
    Transplant Proc; 1994 Aug; 26(4):2246-7. PubMed ID: 7520627
    [No Abstract]   [Full Text] [Related]  

  • 39. Short- and long-term cyclosporine dosage in liver transplantation.
    McCaughan GW; Bookallil MJ; Sheil AG
    Transplant Proc; 1994 Oct; 26(5):2674-5. PubMed ID: 7940837
    [No Abstract]   [Full Text] [Related]  

  • 40. Cyclosporine and bilirubin metabolites compete for the hepatic excretory system.
    Kohlhaw K; Christians U; Sürig T; Lamesch P; Hauss J; Sewing KF; Pichlmayr R
    Transplant Proc; 1994 Oct; 26(5):2798-9. PubMed ID: 7940880
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.